News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 10604
- Sources here
- 14
- Companies here
- 34
Active search
10604 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
67,692 Shares in Vulcan Materials Company $VMC Bought by Tocqueville Asset Management L.P.
Tocqueville Asset Management L.P. has acquired a new stake of 67,692 shares in Vulcan Materials Company (NYSE:VMC), valued at approximately $19.97 million, as reported in their latest SEC filing. This acquisition contributes to the 90.39% institutional ownership of Vulcan Materials stock. The construction materials …
3,990 Shares in United Rentals, Inc. $URI Acquired by NewEdge Wealth LLC
NewEdge Wealth LLC acquired 3,990 shares of United Rentals (NYSE:URI) during the second quarter, valued at approximately $4.52 million. Other institutional investors also increased their holdings, with collective institutional ownership reaching 96.26%. Analysts maintain a "Moderate Buy" rating for United Rentals, which recently surpassed …
Meeder Advisory Services Inc. Purchases Shares of 5,377 Vulcan Materials Company $VMC
Meeder Advisory Services Inc. recently acquired 5,377 shares of Vulcan Materials Company (NYSE:VMC) during the second quarter, valued at approximately $1.59 million. This transaction is part of a broader trend of institutional investors adjusting their holdings in the construction materials company. Analyst ratings for …
Sonoma Pharmaceuticals cancels special meeting due to lack of quorum
Sonoma Pharmaceuticals (NASDAQ:SNOA) announced the cancellation of its adjourned special meeting of stockholders because a quorum was not reached. The meeting, which was intended to address matters detailed in a proxy statement from May 5, 2026, required the presence of holders of one-third of …
Eagle Health Investments LP Acquires New Position in Ionis Pharmaceuticals, Inc. $IONS
Eagle Health Investments LP has acquired a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), purchasing 194,577 shares valued at approximately $15.4 million, making it 2.6% of their portfolio. Despite significant insider selling totaling $18.3 million over the past 90 days, analysts maintain a "Moderate …
SEALSQ commits $10M to satellite firm WISeSat, shares fall 3.65%
SEALSQ Corp has committed $10 million to purchase shares in WISeSat.Space Holdings as part of a de-SPAC transaction, serving as the lead investor in a private placement. Despite the investment, SEALSQ's shares fell, reflecting investor caution around de-SPAC deals, especially with an extended completion …
Great Lakes Advisors LLC Buys Shares of 61,481 ANI Pharmaceuticals, Inc. $ANIP
Great Lakes Advisors LLC has purchased 61,481 shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), valued at approximately $5.1 million, making them a new institutional investor in the company. This comes as ANI Pharmaceuticals exceeded quarterly earnings expectations, reporting adjusted EPS of $2.21 and revenue of …
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of "Hold" from Analysts
Analysts have issued a consensus "Hold" rating for Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), with an average 12-month price target significantly higher than its current trading price. Institutional investors and hedge funds hold a substantial portion of the company's stock, with many increasing their positions recently. …
CSW Industrials, Inc. (NYSE:CSW) Given Average Recommendation of "Moderate Buy" by Analysts
CSW Industrials (NYSE:CSW) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $347.57. The company recently reported strong quarterly earnings, beating estimates with $3.84 EPS and a 33% revenue increase to $350.65 million. Despite some insider sales, …
DCF Advisers LLC Purchases New Holdings in Regeneron Pharmaceuticals, Inc. $REGN
DCF Advisers LLC has acquired a new stake of 9,250 shares in Regeneron Pharmaceuticals (NASDAQ:REGN), valued at approximately $5.77 million, making it their 14th largest holding. This comes as Regeneron reported strong quarterly earnings, beating estimates with $14.29 EPS and a 16.7% year-over-year revenue …
Great Lakes Advisors LLC Invests $8.15 Million in Jazz Pharmaceuticals PLC $JAZZ
Great Lakes Advisors LLC has acquired a new stake of $8.15 million in Jazz Pharmaceuticals PLC, purchasing 33,804 shares in the second quarter. This move makes Great Lakes Advisors LLC own approximately 0.05% of the company's stock. The article also details recent insider stock …
637,500 Shares in Corvus Pharmaceuticals, Inc. $CRVS Bought by DCF Advisers LLC
DCF Advisers LLC recently acquired a significant stake of 637,500 shares in Corvus Pharmaceuticals (NASDAQ:CRVS), valued at approximately $9.5 million. This purchase makes Corvus the sixth largest holding in DCF Advisers' portfolio, representing 1.7% of their total assets. The article also notes recent insider …
Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 1-Year High - What's Next?
Eton Pharmaceuticals (NASDAQ:ETON) recently hit a new 52-week high of $63.83, with its stock trading at $61.48. This surge follows positive analyst upgrades and strong quarterly earnings, where the company reported $0.43 EPS, significantly beating estimates, and revenue of $37.59 million. Despite insider stock …
Diversify Advisory Services LLC Invests $1.93 Million in United Rentals, Inc. $URI
Diversify Advisory Services LLC has purchased a new stake of 1,713 shares in United Rentals, Inc. (NYSE:URI) worth approximately $1.93 million during the second quarter. This move is part of broader institutional interest, with other major firms like BlackRock Inc. and Capital World Investors …
Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP
Aurora Investment Counsel has acquired a new stake of 26,890 shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) during the second quarter, valued at approximately $2.23 million. This comes as several other institutional investors have also adjusted their holdings in the specialty pharmaceutical company. ANI Pharmaceuticals …